NO20043084L - 3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA - Google Patents

3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA

Info

Publication number: NO20043084L
Authority: NO; Norway
Prior art keywords: agnoists; ppar; alpha; selective; phenyl
Prior art date: 2001-12-19

Application number

NO20043084A

Other languages

English (en)

Inventor

Eva-Lotte Alstermark Lindstedt

Anna Maria Persdotter Boije

Patrik Holm

Original Assignee

Astrazeneca Ab Global Ip

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-19

Filing date

2004-07-16

Publication date

2004-07-16

2004-07-16 Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip

2004-07-16 Publication of NO20043084L publication Critical patent/NO20043084L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Peptides Or Proteins (AREA)

NO20043084A 2001-12-19 2004-07-16 3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA NO20043084L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0104333A SE0104333D0 (sv)	2001-12-19	2001-12-19	Therapeutic agents
PCT/GB2002/005743 WO2003051826A1 (en)	2001-12-19	2002-12-18	3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha

Publications (1)

Publication Number	Publication Date
NO20043084L true NO20043084L (no)	2004-07-16

Family

ID=20286432

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043084A NO20043084L (no)	2001-12-19	2004-07-16	3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA

Country Status (26)

Country	Link
US (1)	US7276539B2 (no)
EP (1)	EP1458677B1 (no)
JP (2)	JP3810770B2 (no)
KR (1)	KR20040068589A (no)
CN (1)	CN100343229C (no)
AR (1)	AR038046A1 (no)
AT (1)	ATE428691T1 (no)
AU (1)	AU2002352426A1 (no)
BR (1)	BR0215090A (no)
CA (1)	CA2470066C (no)
CO (1)	CO5590908A2 (no)
DE (1)	DE60232018D1 (no)
ES (1)	ES2324025T3 (no)
HU (1)	HUP0402093A3 (no)
IL (1)	IL162378A0 (no)
IS (1)	IS7303A (no)
MX (1)	MXPA04005992A (no)
NO (1)	NO20043084L (no)
NZ (1)	NZ533365A (no)
PL (1)	PL370623A1 (no)
RU (1)	RU2004117776A (no)
SE (1)	SE0104333D0 (no)
TW (1)	TW200410678A (no)
UA (1)	UA80407C2 (no)
WO (1)	WO2003051826A1 (no)
ZA (1)	ZA200404585B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI282784B (en)	2002-06-20	2007-06-21	Astrazeneca Ab	Therapeutic agents
GB0314075D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314134D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314131D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314130D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314260D0 (en) *	2003-06-19	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0427524D0 (en) *	2004-12-16	2005-01-19	Astrazeneca Ab	Chemical process
GB0427701D0 (en) *	2004-12-17	2005-01-19	Astrazeneca Ab	Therapeutic agents
ES2445049T3 (es)	2007-03-08	2014-02-27	Albireo Ab	Derivados del ácido 3-fenilpropiónico y su uso en el tratamiento de la enfermedad inflamatoria intestinal

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5089514A (en)	1990-06-14	1992-02-18	Pfizer Inc.	3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
US5232945A (en)	1992-07-20	1993-08-03	Pfizer Inc.	3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
WO1999029640A2 (en)	1997-12-05	1999-06-17	Eisai Co., Ltd.	Compositions and methods for modulating the activity of fibroblast growth factor
US6506757B1 (en) *	1998-03-10	2003-01-14	Ono Pharmaceutical Co., Ltd.	Carboxylic acid derivatives and drugs containing the same as the active ingredient
SE9801990D0 (sv)	1998-06-04	1998-06-04	Astra Ab	New 3-aryl propionic acid derivatives and analogs
MA26634A1 (fr) *	1998-06-04	2004-12-20	Astra Ab	Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801992D0 (sv) *	1998-06-04	1998-06-04	Astra Ab	New 3-aryl-2-hydroxypropionic acid derivative I
GB9822473D0 (en) *	1998-10-16	1998-12-09	Glaxo Group Ltd	Chemical compounds
CN1331862C (zh) *	1999-04-28	2007-08-15	萨诺费－阿文蒂斯德国有限公司	作为ppar受体配体的二芳基酸衍生物
TWI262185B (en)	1999-10-01	2006-09-21	Eisai Co Ltd	Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
TW574193B (en)	1999-12-03	2004-02-01	Astrazeneca Ab	Novel phenalkyloxy-phenyl derivatives, pharmaceutical composition containing the same and their uses
SE9904421D0 (sv)	1999-12-03	1999-12-03	Astra Ab	New compounds
SE0000772D0 (sv)	2000-03-08	2000-03-08	Astrazeneca Ab	Chemical compounds
BR0109107A (pt)	2000-03-09	2002-12-03	Aventis Pharma Gmbh	Usos terapêuticos de mediadores ppar
SE0003766D0 (sv)	2000-10-18	2000-10-18	Astrazeneca Ab	Novel formulation
EG26979A (en)	2000-12-21	2015-03-01	Astrazeneca Ab	Chemical compounds
TWI311133B (en)	2001-04-20	2009-06-21	Eisai R&D Man Co Ltd	Carboxylic acid derivativeand the salt thereof
SE0101978D0 (sv)	2001-06-01	2001-06-01	Astrazeneca Ab	New compounds
GB0121337D0 (en)	2001-09-04	2001-10-24	Astrazeneca Ab	Chemical compounds
GB0121622D0 (en)	2001-09-07	2001-10-31	Astrazeneca Ab	Chemical compounds
GB0121621D0 (en)	2001-09-07	2001-10-31	Astrazeneca Ab	Chemical compounds
PL216023B1 (pl)	2001-09-08	2014-02-28	Astrazeneca Ab	Pochodna benzotiadiazepiny, kompozycja farmaceutyczna zawierajaca pochodna benzotiadiazepiny oraz zastosowania pochodnej benzotiadiazepiny
SE0104334D0 (sv)	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
GB0229931D0 (en)	2002-12-21	2003-01-29	Astrazeneca Ab	Therapeutic agents
GB0209467D0 (en)	2002-04-25	2002-06-05	Astrazeneca Ab	Chemical compounds
GB0213669D0 (en)	2002-06-14	2002-07-24	Astrazeneca Ab	Chemical compounds
SE0201937D0 (sv)	2002-06-20	2002-06-20	Astrazeneca Ab	Therapeutic agents
TWI282784B (en)	2002-06-20	2007-06-21	Astrazeneca Ab	Therapeutic agents
SE0201936D0 (sv)	2002-06-20	2002-06-20	Astrazeneca Ab	Therapeutic agents
GB0314075D0 (en)	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314130D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314131D0 (en)	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314078D0 (en)	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314136D0 (en)	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314129D0 (en)	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314260D0 (en)	2003-06-19	2003-07-23	Astrazeneca Ab	Therapeutic agents

2001
- 2001-12-19 SE SE0104333A patent/SE0104333D0/xx unknown
2002
- 2002-12-18 ES ES02788144T patent/ES2324025T3/es not_active Expired - Lifetime
- 2002-12-18 EP EP02788144A patent/EP1458677B1/en not_active Expired - Lifetime
- 2002-12-18 HU HU0402093A patent/HUP0402093A3/hu unknown
- 2002-12-18 KR KR10-2004-7009348A patent/KR20040068589A/ko not_active Withdrawn
- 2002-12-18 IL IL16237802A patent/IL162378A0/xx unknown
- 2002-12-18 CA CA002470066A patent/CA2470066C/en not_active Expired - Fee Related
- 2002-12-18 AU AU2002352426A patent/AU2002352426A1/en not_active Abandoned
- 2002-12-18 AT AT02788144T patent/ATE428691T1/de not_active IP Right Cessation
- 2002-12-18 PL PL02370623A patent/PL370623A1/xx unknown
- 2002-12-18 NZ NZ533365A patent/NZ533365A/en unknown
- 2002-12-18 WO PCT/GB2002/005743 patent/WO2003051826A1/en not_active Ceased
- 2002-12-18 TW TW091136517A patent/TW200410678A/zh unknown
- 2002-12-18 JP JP2003552714A patent/JP3810770B2/ja not_active Expired - Fee Related
- 2002-12-18 DE DE60232018T patent/DE60232018D1/de not_active Expired - Lifetime
- 2002-12-18 US US10/499,042 patent/US7276539B2/en not_active Expired - Fee Related
- 2002-12-18 UA UA20040604534A patent/UA80407C2/uk unknown
- 2002-12-18 RU RU2004117776/04A patent/RU2004117776A/ru not_active Application Discontinuation
- 2002-12-18 CN CNB028281225A patent/CN100343229C/zh not_active Expired - Fee Related
- 2002-12-18 MX MXPA04005992A patent/MXPA04005992A/es not_active Application Discontinuation
- 2002-12-18 BR BR0215090-5A patent/BR0215090A/pt not_active IP Right Cessation
- 2002-12-19 AR ARP020105003A patent/AR038046A1/es not_active Application Discontinuation
2004
- 2004-06-08 IS IS7303A patent/IS7303A/is unknown
- 2004-06-09 ZA ZA200404585A patent/ZA200404585B/en unknown
- 2004-07-16 NO NO20043084A patent/NO20043084L/no not_active Application Discontinuation
- 2004-07-16 CO CO04068143A patent/CO5590908A2/es not_active Application Discontinuation
2006
- 2006-03-20 JP JP2006077296A patent/JP2006241162A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
ATE428691T1 (de)	2009-05-15
HUP0402093A2 (hu)	2005-02-28
HK1068866A1 (en)	2005-05-06
CN1620430A (zh)	2005-05-25
ES2324025T3 (es)	2009-07-29
ZA200404585B (en)	2005-10-26
IL162378A0 (en)	2005-11-20
JP3810770B2 (ja)	2006-08-16
UA80407C2 (en)	2007-09-25
KR20040068589A (ko)	2004-07-31
AR038046A1 (es)	2004-12-22
MXPA04005992A (es)	2004-09-27
WO2003051826A1 (en)	2003-06-26
PL370623A1 (en)	2005-05-30
EP1458677A1 (en)	2004-09-22
AU2002352426A1 (en)	2003-06-30
IS7303A (is)	2004-06-08
US7276539B2 (en)	2007-10-02
JP2006241162A (ja)	2006-09-14
US20050215630A1 (en)	2005-09-29
SE0104333D0 (sv)	2001-12-19
RU2004117776A (ru)	2006-01-10
EP1458677B1 (en)	2009-04-15
CA2470066C (en)	2007-04-10
CA2470066A1 (en)	2003-06-26
TW200410678A (en)	2004-07-01
DE60232018D1 (de)	2009-05-28
NZ533365A (en)	2006-05-26
JP2005511785A (ja)	2005-04-28
HUP0402093A3 (en)	2008-08-28
CN100343229C (zh)	2007-10-17
BR0215090A (pt)	2004-11-16
CO5590908A2 (es)	2005-12-30

Publication	Publication Date	Title
NO20043158L (no)	2004-09-16	Substituerte kinazolinderivater som inhibitorer av aurorakinaser
NO20030867L (no)	2003-02-25	Hydroksamderivater anvendelig som deacetylaseinhibitorer
NO20023828L (no)	2002-09-30	Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
NO20031784D0 (no)	2003-04-22	Heteroarylalkylpiperazinderivater som fettsyre- oksydasjonsinhibitorer
NO20023645L (no)	2002-10-01	Selektiv krystallisering av natrium 3-pyridyl-1- hydroksyetyliden-1,1-bisfosfonsyre som hemipentahydrat ellermonohydrat
NO20033618L (no)	2003-10-15	Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
NO20021042L (no)	2002-04-30	Benzofenoner som inhibitorer av reverstranskriptaser
NO20032181D0 (no)	2003-05-14	Anvendelse av CCI-779 som et antineoplastisk middel
NO20031450D0 (no)	2003-03-28	Fumarsyrederivater som NF-kappa B inhibitorer
NO20040356L (no)	2004-03-19	Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
NO20030055D0 (no)	2003-01-06	Colchinolderivater som angiogenese inhibitorer
NO20050426L (no)	2005-03-29	Arylkarbonylderivater som terapeutiske midler
NO20034307L (no)	2003-11-27	Cyklopropylindol-derivater som selektive serotonin- gjenopptaksinhibitorer
NO20026262L (no)	2002-12-27	Cyklopentyl-substituerte glutaramidderivater som inhibitorer av nöytral endopeptidase
IS6987A (is)	2003-10-09	Nýjar súlfónsýru afleiður
DK1178986T3 (da)	2004-07-05	Furanonderivater som inhibitorer af cathepsin S
NO20040860L (no)	2004-04-22	Farmasoytisk sammensetning som innbefatter lumiracoxib
NO20021959L (no)	2002-05-29	Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer
NO20043084L (no)	2004-07-16	3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA
NO20035206D0 (no)	2003-11-24	Pyrimidin-derivater anvendelige som selektive COX-2- inhibitorer
NO20021965L (no)	2002-06-13	Hydroksamsyrederivat som inhibitor av dannelse av opplöselig, human CD23
NO20030820L (no)	2003-04-22	Anvendelse av vitamin D derivater som benresorpsjons inhibitorer
NO20015033L (no)	2001-11-21	Anvendelse av maduraftalazinderivater som inhibitorer av proinflammatoriske cytokiner
NO20020308D0 (no)	2002-01-21	Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten
DK1373249T3 (da)	2005-08-22	Imidazolidinderivater, deres fremstilling og deres anvendelse som anti-inflammatorisk middel

Legal Events

Date	Code	Title	Description
2008-07-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application